Neurological Dysfunction 2005 STUDENT COPY(1)

Embed Size (px)

Citation preview

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    1/100

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    2/100

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    3/100

    Migraines

    Tend to have pattern

    Possible etiology:

    Familial

    Stress

    Hormonal

    Three types of migraines:

    Classic Common

    Complicated

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    4/100

    Classic Migraines

    Aura

    Transient

    neurological

    disturbance

    Crescendo quality

    Unilateral / Spreads

    across

    Acutely ill

    Irritable

    N/V

    Sensitive to

    Light Sounds

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    5/100

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    6/100

    Migraines-Rx(Pharmacological)

    Combination drugs:

    Analgesics

    VasoconstrictorsAntiemetics

    Antidepressants

    Sedatives

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    7/100

    Migraines-Rx(Pharmacological cont.)

    Prevention

    NSAIDs

    Beta blockers Calcium Cannel

    Blockers

    Antidepressants

    Abortive Therapy

    NSAIDs

    Ergotaminederivatives

    Triptan

    preparations

    Antiemetics

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    8/100

    Cluster Headaches

    Excruciating pain

    No aura

    Unilateral

    Lacrimation

    Miotic pupil on affected side

    Facial sweating

    Recur in clusters

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    9/100

    Cluster Headaches

    Management

    Analgesics

    Relaxation techniques

    Meditation

    Acupuncture

    Massage therapy

    100% O2very effective

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    10/100

    Seizures

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    11/100

    Seizures SZ) Pathophysiology

    Sudden / Excessive / Disorderly

    Electrical discharge across the brain

    Results:

    Violent & involuntary contractions of agroup of muscles

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    12/100

    Seizures cont) Epilepsy

    Chronic disorder

    Characterized by recurrent seizures

    Status epilepticus

    Generalized seizures

    At frequent intervals

    Person cannot regain full consciousness EMERGENCY !!!

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    13/100

    Secondary EpilepsyPossible causes

    Head trauma

    Brain tumors

    Aneurysms

    Meningitis / Other infections Vascular Ds

    Metabolic

    F & E imbalance

    Meds Kidney & Liver failure / HD

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    14/100

    Seizures Classification) Generalized seizures

    Tonic-clonic (grand mal)

    Absence (petit mal)

    Myoclonic Atonic

    Partial seizures Simple partial

    Complex partial

    Unclassified

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    15/100

    Generalized Sz:TonicClonic

    Usually preceded by aura

    Tonic phase

    Immediate LOC Clonic phase

    Postictal phase

    May have incontinence

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    16/100

    Generalized Sz:Absence Sz Grand Mal)

    No aura

    Brief LOC

    Blank stare, daydreaming May have little tonic-clonic movements

    ie: Twitching of eyelids

    No postictal state

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    17/100

    Generalized Sz cont) Myoclonic Sz

    Brief jerking or stiffening of extremities

    No aura

    No LOC

    No postictal period

    Atonic Sz

    Sudden loss of muscle tone

    Usually person falls Drop Attack

    Postictal confusion

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    18/100

    Partial Seizures Partial complex

    LOC

    Automatism

    Lip smacking

    Patting

    Picking

    ? Amnesia

    Simple partial

    Often aura

    No LOC

    Unilateral

    movements of an

    extremity

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    19/100

    Antiepileptic Drugs *Phenytoin

    Dilantin

    *Carbamazepine Tegretol

    Phenobarbital Lumnial

    Clonazepam Klonopin

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    20/100

    Antiepileptic Drugs cont) *Divalproex

    Depakote

    Gabapentin Neurontin

    Diazepam Valium

    Lorazepam Ativan

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    21/100

    Seizures:Assessment

    Subjective Data:

    Pt understanding of Ds, triggering factors

    Frequency, length of episodes

    Pt knowledge of meds

    Pt compliance with meds

    Description of Sz Aura

    Postictal state

    Incontinence

    Loss of consciousness, amnesia

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    22/100

    Seizures:Assessment cont)

    Objective Data:

    Description of Sz

    Behavior during episode

    Characteristics of SzFrequency

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    23/100

    Assessment cont)Diagnostic Data

    EEG, CT scan, MRI, LP

    CBC, BUN / Cr, Lytes

    BS, LFTs, UA

    Any underlying disorder

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    24/100

    Seizures:Major Nsg Dx

    **Risk for injury

    Major consideration

    Knowledge deficit Risk for isolation

    Risk for depression

    Risk for drug side-effects..

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    25/100

    SeizuresNOC

    Injury prevention

    Awareness of:

    Ds, Rx, & possible side-effects

    Isolation Avoidance

    Depression

    Avoidance Normalization of daily living ..

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    26/100

    Seizure Precautions

    May vary based one institutions

    In general:

    O2 & suction set up Airway at bedside

    INT

    Padded side rails (controversial)

    Bed in low position

    Side rails up

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    27/100

    SeizuresNIC Interventions general)

    Protect client from injury

    No restraints

    Do not place objects in mouth

    Turn client to side as soon as possible Loosen restrictive clothing

    Maintain airway

    Suction if needed

    VS / Neurological assessment

    Allow to rest

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    28/100

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    29/100

    Sz - Client Education Medications:

    Name, dosage, frequency

    Take meds as prescribed

    Do not miss dose What to do if it happens

    Side effects

    Avoid ETOH & excessive fatigue

    Dont take any meds including OTCs MD knowledge

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    30/100

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    31/100

    Meningitis

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    32/100

    Meningitis

    Inflammation of meninges

    Two most common causes: Bacterial & Viral

    Organism enters subarachnoid space Inflammation / WBCs respond

    Exudates forms

    Hydrocephalus / Cerebral edema

    Increased ICP

    Death if not treated

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    33/100

    Bacterial Meningitis

    Dx made by H & P

    Confirmed by isolation of organism from CSF

    LP essential part of work up

    CSF findings: Cloudy

    Pressure

    Proteins

    Glucose WBCs

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    34/100

    Meningitis:Clinical Presentation

    H/A, N/V

    Back pain

    Fever / Chills

    Seizures Cloudy sensorium

    Petichial rash

    Nuchal rigidity

    Brudzinski sign

    Kernigs sign

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    35/100

    Meningitis cont) Medical Rx

    IV ATBX

    Corticosteroids

    Anticonvulsants

    Analgesics

    F & E

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    36/100

    Meningitis-NSG ProcessAssessment

    Subjective

    H/A, muscle aches, nuchal rigidity, rash

    Objective LOC

    Pupillary reaction, eye movements

    Motor response

    Nuchal rigidity, Brudzinski & Kernig signs

    Changes in attention, memory, personality

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    37/100

    Meningitis - NSG Dxs Altered cerebral perfusion

    Altered comfort: pain

    Hyperthermia Risk for fluid volume deficit

    Potential for injury

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    38/100

    Meningitis - Management

    NOC

    Maintain cerebral perfusion

    Provide comfort

    Avoid hyperthermia

    Maintain F & E balance

    Prevent injury

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    39/100

    Meningitis - Management

    Frequent assessment

    Monitor for complications

    Administer atbx

    Promote comfort

    Infection control

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    40/100

    Multiple Sclerosis

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    41/100

    Multiple Sclerosis (MS)

    Definition

    Chronic,progressive, degenerative Ds affecting

    myelin sheath and conduction pathway of CNS Pathophysiology

    Inflammatory response thickens myelin

    Damaged myelin removed Scar tissue formed

    Impulses not transmitted as effectively

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    42/100

    Multiple SclerosisEpidemiology

    Prevalence:

    Young adults / Female > males

    Difficult to Dx initially

    Symptoms vague & non lasting

    Possible causes

    Genetic, environmentalViral, immunological

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    43/100

    Various Types of MSMost Common

    Benign Few episodes / Mild attacks Minimal or no disability

    Relapsing / Remitting (classic) Increasingly frequent attacks After exacerbation pt returns to baseline

    Progressive / Relapsing No periods of remission

    Progressive cumulative

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    44/100

    Multiple SclerosisClinical Presentation

    Motor

    Fatigue

    Stiffness

    Spasms

    Clonus

    Babinski

    Hyperactive DTRs

    Dysarthria

    Ataxia Tremors with

    activity

    Poor coordination

    Muscle atrophy

    Spasticity

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    45/100

    Multiple SclerosisClinical Presentation (cont)

    Visual

    Loss of vision

    Partial

    Total

    Blurred vision

    Changes inperiph vision

    Diplopia

    Nystagmus Diorder affecting

    any of the 3

    mechanismsCorsetti

    Multiple Sclerosis

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    46/100

    Multiple SclerosisClinical Presentation (cont)

    Sensory

    Pain, touch, temp

    perception

    Position &

    vibratory sense

    Numbness, tingling,

    burning

    B & B dysfunction

    Frequency

    Urgency

    Incontinence

    Constipation

    Sexual dysfunction

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    47/100

    Multiple SclerosisClinical Presentation (cont)

    Psychological /

    Cognitive

    Early: Anxiety

    Apathy

    Euphoria

    Late:

    Inattentiveness

    Depression

    Confusion

    Memory loss

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    48/100

    MSLabs/Diagnostic CSF

    May have increased IgG bands

    CT scan

    May show density in white matter

    Cerebral / Optic atrophy

    MRI

    Presence of plaque

    Diagnostic for MS

    EMG

    Abnormalities in acute phase

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    49/100

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    50/100

    MS Medical Rx Steroids (acute)

    Side effects: Cause major problems with blood sugars

    Immunocompromise

    Give in the AM with FOOD.

    Heart failurefluid retention

    HTX

    Electolyte imbalance

    Psychosis

    Antineoplastics (acute)

    MTX

    Cytoxan

    Immunomodulators (long term) 1x day or 1x week

    Avonex

    Betaseron

    Copaxone Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    51/100

    MS: Adjunctive Medical Rx Muscle Spasticity

    Baclofen, Valium (problematic: long half-life)

    Paresthesia (numbness and tingling) Tegretol (anticonvulsant) Neurontin (anticonvulsant) - Tricyclic antidepressants

    Cerebellar ataxia Inderal Klonopin (highly addictive drug)

    Bladder dysfunction (spastic bladder-can expel foley) Or atonic bladder

    Urecholine (for contractions distention and retention)

    , Ditropan (neurogenic bladder) Flomax

    Do a cystogram to determine type of dysfunction and then they prescribe the appropriate medications.

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    52/100

    MS AssessmentClinical manifestations are different

    Subjective

    Pts understanding of Ds &/or Rx

    Presence of S &S of MS

    Frequency & duration of exacerbation

    Response to RX

    Objective Physical exam

    Diagnostic data

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    53/100

    MS-most common: Possible Nsg Dxs

    Impaired physical mobility

    Self care deficit

    Sensory/perceptual alteration

    High risk for injury

    Alteration in B & B functions

    Body image disturbance

    Altered skin integrity Many more..

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    54/100

    MS-Possible Nsg Dxs

    NOC Labels

    Based on the particular Nsg Dx ie:

    Mobility

    Self care.

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    55/100

    MS-NIC to Improve Mobility

    Stretching exercises daily

    Active / Passive ROM

    Avoid fatigue / Frequent rest periods

    Avoid rigorous activity

    Avoid excess heat

    Rest with exacerbation periods

    Assistive devices Prevent / Manage problems of immobility

    Corsetti

    MS NIC to Prevent / Manage

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    56/100

    MS-NIC to Prevent / Manage

    B & B Complications

    Avoid urinary retention

    Adequate fluid intake

    Bladder training

    Suprapubic / foleychronic UTIs

    Clock voiding every 1-2 hours

    Hydration

    Meds

    Prevent constipation

    Stress routine

    Laxatives Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    57/100

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    58/100

    ALS)Amyotrophic Lateral Sclerosis

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    59/100

    Amyotrophic Lateral SclerosisALS)

    Also cAlled lou GehriGs dsProgressive / Degenerative Ds

    Involves motor system

    Paralysis & death most likely fromrespiratory failure

    Usually w/in 2-5 yrs

    Sensory & ANS not involved

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    60/100

    ALS-Clinical Manifestations Progressive weakness of:

    Shoulders / Neck / Trunk

    Arms / Legs

    Progressive difficulty with:

    Swallowing

    SpeakingBreathing

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    61/100

    ALS- General NSG Interventions NSG interventions aimed at:

    Maintaining respirations / Preventing aspiration

    Preventing / Managing problems of immobility

    Meeting nutritional needs

    Promoting comfort

    Providing emotional support

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    62/100

    (GBS)Guillain Barre` Syndrome

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    63/100

    Guillain Barre` Syndrome

    Acute inflammatory disorder

    Degeneration of peripheral nerve myelin sheath

    ? Autoimmune disorder

    Often preceded by:

    URI / GI infection / Viral infection / Vaccination

    Three stages:

    Initial period / Plateau period / Recovery

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    64/100

    Types of GBS Ascending GBS- Most common

    Symptoms begin in Lower Extremities & progress upward LOC, cerebral functions, pupillary reactions

    Not affected

    Pure motor GBS Similar to above except sensory component

    Descending GBS Symptoms move from head to toe

    Word finding difficultiessymptoms over 2-3 days. Most common and serious problem is resiratory distress and failure.

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    65/100

    GBS-Clinical Manifestations Motor:

    Muscle weakness / Paralysis

    No atrophy

    Or no DTRs **Respiratory compromise

    Sensory:

    Paresthesias

    Pain

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    66/100

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    67/100

    GBS Medical Rx Immunoglobulin

    Plasmapheresis

    Immunosuppressive

    Drugs for symptomatic relief

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    68/100

    GBS NSG Dxs Ineffective breathing

    Impaired physical mobility

    Anxiety / Powerlessness Self care deficits

    Impaired communication

    Altered comfort

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    69/100

    GBS-Management

    NOC / NIC aimed at:

    **Maintaining respiration

    *Avoiding complications of immobility

    Promoting adequate nutrition

    Maintaining communication

    Relieving pain

    Reducing anxiety

    Corsetti

    GBS

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    70/100

    GBS

    Management

    Close monitoring of respiratory status May be on respirator

    Monitor for / Prevent DVT / PE

    ATC

    TEDS / Sequential Compression Boots

    Active & passive ROM

    Mobilization Prevent complications of immobility

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    71/100

    Myasthenia Gravis MG) Definition

    Chronic Ds involving # & effectiveness of ACh @neuromuscular junction

    Results

    Impaired muscle contraction

    Etiology

    Believed autoimmune

    Possible genetic factors

    Thymus gland often abnormal

    Strong association with hypothyroidism

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    72/100

    MG-Clinical Manifestations Weakness and fatigue

    Increases with exercise

    Improves with rest

    Ocular symptoms

    **Ptosis

    Weak & incomplete eye closure

    Diplopia

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    73/100

    MG-Clinical Manifestations cont)

    Weakness of facial muscles Impaired chewing / Swallowing / Wt loss Slurred speech

    Respiratory compromise Death if untreated

    Posture Inability to hold head upright

    Fatigue Weakness of limbs and trunk

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    74/100

    MG - Diagnosis H & P

    Tensilon test

    EMG CXR / CT

    TSH

    Acetylcholine receptor antibodies (AchR)

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    75/100

    MG Drug Rx Three groups:

    Anticholinesterases

    Corticosteroids

    Immunosuppressant

    Meds must be given on time

    Monitor response

    Side-effects of anticholinesterases mimicexacerbation of Ds

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    76/100

    Cholinergic vsMyasthenic Crisis

    1st

    Due to:

    Cholinesteraseinhibitor excess

    Rx usually is

    AtropineMay need vent

    2nd

    MG Exacerbation

    Responds toanticholinesteras

    e ie: Tensilon

    Meds adjustedwith activity

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    77/100

    MG: Triggering Factors

    URI

    Other infections

    Anxiety / Stress

    Menstruations

    Pregnancy

    Anesthesia / Surgery

    Various meds

    ETOH

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    78/100

    MG NOC - NIC Focuses) Monitor respiratory status

    Promote self care

    Provide education

    Rx / Side-effects

    Assist with nutritional support

    Provide eye protection

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    79/100

    pArkinsons ds (pd) Movement disorder

    ChronicProgressive

    Degenerative Involves:

    Basal gangliaSubstantia nigra

    Corsetti

    Normal physiology of

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    80/100

    movements Basal ganglia stimulation

    Inhibition of muscle tone

    Refined, smooth movements

    Process accomplished by: Balance of Dopamine & Acethylcholine (Ach)

    Dopamine From substantia nigra

    Inhibitory (blocks actions of Ach)

    Ach From nerve endings

    Excitatory

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    81/100

    PD Pathophysiology Widespread substantia nigra

    degeneration

    Dopamine levels

    Excessive excitation of selectedneurons by ACh

    Inability to initiate movements

    Loss of refined movements

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    82/100

    Stages of PD Stage I

    Very mild Ds

    *Unilateral limb

    involvementMinimal

    weakness

    Hand / Armtremors

    Stage II

    Mild Ds

    Bilateral limbinvolvement

    Mask-like facies

    Slow shufflinggait

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    83/100

    Stages of PD cont) Stage III

    Moderate Ds

    Significant gait

    disturbance Generalized disability

    Stage IV Severe Ds

    Severe disability Akinesia

    Rigidity

    Stage V

    End stage Ds

    Completedependence

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    84/100

    PD Key Features Posture

    Stooped

    Flexed trunk / Forward extension

    Abducted / Flexed fingers Slightly dorsiflexed wrists

    Gait Slow & shuffling

    Short & hesitant steps

    Propulsive / Difficulty stopping quickly

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    85/100

    PD Key Features cont) Face

    Mask-like facies

    DroolingDifficulty chewing

    & swallowing

    Speech

    Soft, low pitched

    DysarthriaEcholalia

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    86/100

    PD Key Features cont) Motor (cont)

    Arms

    Little swing

    Tremors

    Pill-rolling

    Cog wheeling

    Change in

    handwritingGeneral

    Bradykinesia

    Akinesia Fatigue

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    87/100

    PD Key Features cont) Autonomic

    dysfunctions

    Postural hypotension

    Excess perspirations Oily skin

    Seborrhea

    Blepharospasms Constipation

    Psychosocialimplications

    Emotional labile

    Depression

    Paranoia

    Mood swings

    Delayed reactions

    Cognitive impairment

    Late in Ds

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    88/100

    PD - Collaborative Management Drug Rx

    Dopaminergic agents

    Drug of choice by many

    Carbidopa-levadopa (Sinemet) Amantadine (Symmetrel)

    Anticholinergic agents

    Decrease excitatory effects of ACh

    Cogentin, Artane, Cogentin

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    89/100

    PD Drug Rx cont) Dopamine agonists

    Stimulate dopaminergic receptors

    Parlodel

    Mirapex

    Permax Requip

    COMT inhibitors

    Block enzyme that inactivates dopamine

    Comtan Tasmar

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    90/100

    PD Non-Pharm Rx Surgery

    Last resort

    Stereotactic Pallidotomy

    Thalamotomy

    Deep Brain Stimulation

    (DBS) Fetal tissue transplantation

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    91/100

    PD Common NSG Dxs Impaired mobility

    Risk for injury

    Self care deficit

    Impaired airway clearance Impaired communication

    Altered nutrition

    B & B dysfunction Ineffective coping..

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    92/100

    PD NSG InterventionsGeneral)

    Evaluate understanding of Ds / Rx Educate / Support client & family in long

    term management of complications:

    Immobility Infections

    B & B problems

    Malnutrition /Aspiration

    Isolation / Depression / Stress

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    93/100

    Alzheimers diseAse Ad) Characteristics:

    Memory loss

    Impaired judgment

    Changes in personality Increasingly cognitive impairment

    Severe physical deterioration

    Death secondary to complications ofimmobility

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    94/100

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    95/100

    Stages of ADStage I Mild Symptoms)

    ***Forgetfulness Mild memory loss

    Short attention span

    Decrease interest in personal affairs

    Subtle changes in personality and behavior

    Impaired ability to acquire new memories

    LTM usually intact

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    96/100

    Stages of AD cont)Stage II Moderate Symptoms)

    Profound memory loss

    ***Confusion, difficulty with ADLs

    Significant cognitive impairment Anomia / Agnosia / Apraxia / Aphasia

    Severe loss of judgment

    Abusiveness, agitation, paranoia

    Insomnia ***Wandering, pacing

    Corsetti

    Stages of AD cont)

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    97/100

    Stage III Severe Symptoms) Severe dementia

    Profound impairment of all cognitivefunctions

    Loss of speech

    Loss of appetite / wgt loss

    Loss of bladder and bowel control

    Total dependence on caregiver

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    98/100

    Diagnostic Criteria for Probable AD

    Clinical presentation

    Mental status testing

    Confirmed by neuropsychological testing

    Deficits in 2 or > cognitive areas: Memory, attention, language, personality, visuospatial

    functions

    Progressive Cognitive deterioration / No delirium

    Ages 40-90

    No systemic illnesses affecting brain

    R/O other possible causes

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    99/100

    AD Common NSG Dxs Altered thought process Risk for injury

    Self care deficit

    B & B dysfunction

    Altered nutrition

    Altered skin integrity

    Many more.

    Corsetti

  • 8/13/2019 Neurological Dysfunction 2005 STUDENT COPY(1)

    100/100

    AD General NSG Interventions Provide consistency Promote independence

    Promote bowel and bladder continence

    Assist with recognition of familiar faces

    Promote communication

    Prevent injuries

    Provide family education